Back to $1
- Forums
- ASX - By Stock
- NEU
- Ann: Plans for Phase 3 trial in Rett syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
11.0%
!
$13.92

Ann: Plans for Phase 3 trial in Rett syndrome, page-23
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.92 |
Change
1.380(11.0%) |
Mkt cap ! $1.730B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $8.583M | 627.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 1288 | $13.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.92 | 626 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 440 | 13.890 |
8 | 621 | 13.880 |
7 | 3030 | 13.870 |
4 | 457 | 13.860 |
5 | 1224 | 13.850 |
Price($) | Vol. | No. |
---|---|---|
13.910 | 270 | 2 |
13.920 | 1116 | 5 |
13.930 | 2154 | 5 |
13.940 | 1124 | 3 |
13.950 | 1085 | 5 |
Last trade - 11.52am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online